Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
A Gene Network Regulating Lysosomal Biogenesis and Function
2009 StandoutScience
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
2012
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
Chitotriosidase activity in patients with interstitial lung diseases
2007
Niemann-Pick disease type C
2010 Standout
Changes in Lipidome Composition during Brain Development in Humans, Chimpanzees, and Macaque Monkeys
2017 StandoutNobel
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
A new definition of neuropathic pain
2011 Standout
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Secondary lipid accumulation in lysosomal disease
2008
Heritable and non-heritable uncommon causes of stroke
2020
The cellular pathology of lysosomal diseases
2011
Guidelines for the Primary Prevention of Stroke
2010
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease
2012
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Revealing the human mucinome
2022 StandoutNobel
Three-dimensional human facial morphologies as robust aging markers
2015
Small fiber neuropathy in Fabry disease
2012
Glycosylation in health and disease
2019
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
2009
Lysosomal disorders: From storage to cellular damage
2008
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Sphingolipids and lysosomal pathologies
2013
Glycosphingolipids—Nature, Function, and Pharmacological Modulation
2009
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Glycoproteomics
2022 StandoutNobel
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
2015
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Enzyme replacement therapy for Anderson-Fabry disease
2016
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
2012 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Works of Anouk C. Vedder being referenced
Home treatment for Fabry disease: practice guidelines based on 3 years experience in The Netherlands
2005
Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease
2007
Plasma chitotriosidase in male Fabry patients: A marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy
2006
Treatment of Fabry disease with different dosing regimens of agalsidase: Effects on antibody formation and GL-3
2008
Three-dimensional face shape in Fabry disease
2007
Treatment of Fabry Disease: Outcome of a Comparative Trial with Agalsidase Alfa or Beta at a Dose of 0.2 mg/kg
2007
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
2008